3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
3
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Prostatic Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Retinoblastoma
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mouth Neoplasms
1
Interventions
Rituximab
23
Cyclophosphamide
15
ibrutinib
14
acalabrutinib
13
CT-P10
10
Lenalidomide
8
Bendamustine Hydrochloride
8
venetoclax
7
fludarabine
7
Cytarabine
6
fludarabine phosphate
5
zanubrutinib
4
obinutuzumab
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
pirtobrutinib
3
Whole-Body Irradiation
3
Tacrolimus
3
Mycophenolic Acid
3
Melphalan
3
Etoposide
3
palbociclib
2
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
brexucabtagene autoleucel
2
auricularum
2
Vincristine
2
Stem Cell Transplantation
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphoma, Mantle-Cell
×
Observation
×
Clear all
NCT00877214
2024-08-22
MAINTAIN
University of Giessen
Phase 3
Active not recruiting
1,272 enrolled